DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Sign in and take the values quiz to see how this bill lines up with what you've said.
This bill amends the Medicare program to extend the deadline for payment increases for biosimilar biological products from 2027 to 2032. Biosimilars are lower-cost alternatives to brand-name biologic drugs; this change would allow Medicare to continue providing enhanced reimbursement rates for these products for an additional five years.
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
Sign in to see how your representatives voted on this bill.